Lanean...
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
In chronic lymphocytic leukemia (CLL), the worst prognosis is associated with TP53 defects with the affected patients being potentially directed to alternative treatment. Therapy administration was shown to drive the selection of new TP53 mutations in CLL. Using ultra-deep next-generation sequencing...
Gorde:
| Argitaratua izan da: | Leukemia |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396398/ https://ncbi.nlm.nih.gov/pubmed/25287991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.297 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|